Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.800
+0.032 (4.22%)
At close: Mar 9, 2026, 4:00 PM EDT
0.820
+0.020 (2.50%)
After-hours: Mar 9, 2026, 5:08 PM EDT
Dyadic International Employees
Dyadic International had 6 employees as of December 31, 2024. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
$557,033
Profits / Employee
-$1,224,708
Market Cap
28.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Kyntra Bio | 225 |
| IGC Pharma | 70 |
| Passage Bio | 60 |
| Evaxion | 46 |
| Cue Biopharma | 41 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| FibroBiologics | 15 |
DYAI News
- 5 days ago - Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) - GlobeNewsWire
- 7 days ago - Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone - GlobeNewsWire
- 20 days ago - Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin - GlobeNewsWire
- 3 months ago - Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic's Recombinant Growth Factors and Media Proteins - GlobeNewsWire
- 3 months ago - Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript - Seeking Alpha
- 3 months ago - Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets - GlobeNewsWire
- 4 months ago - Dyadic International, Inc. (DYAI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress - GlobeNewsWire